GCG and asthma: In a recent population-based study comparing the risk of asthma exacerbations between glucagon-like peptide 1 (GLP-1) agonists and other antidiabetic agents, SGLT2I use was associated with a higher rate of exacerbations.23 However, no direct comparison between SGLT2Is and DPP4Is was made.23 This study provided a clinical comparison of the association of OAD with SGLT2Is and DPP4Is.